High-flying memory chip stocks like Sandisk and Micron bounced back early Thursday after dropping in pre-market trading following a Nikkei report that some PC makers are considering turning to Chinese companies — such as ChangXin Memory Technologies — for supplies amid a historic chip price spike sent them down in the premarket session.
Chinese EV maker Nio on Thursday said it expects to achieve its first-ever quarterly profit in its fourth quarter. Its US-traded ADRs rose more than 6% in premarket trading.
Based on a preliminary assessment, Nio projects Q4 adjusted profit from operations of between $100 million and $172 million. Wall Street analysts polled by FactSet estimated a Q4 adjusted operating loss of $19 million.
Nio attributed the preliminary results to sustained sales volume growth, vehicle margin optimization, and cost reductions. Nio delivered 124,807 vehicles in its fourth quarter, which ended in December, up 72% year over year.
Novo said in a statement "will take legal and regulatory action to protect patients, our intellectual property and the integrity of the US gold-standard drug approval framework."
Nvidia is rebounding from its worst five-session decline since April this morning after Hon Hai Technology Group posted massive sales growth for January, up 35.5% year on year.
Hon Hai, more commonly known as Foxconn, indicated that its cloud and networking products division (which includes servers for data centers) was its top source of sales growth.
“Shipments of AI racks continue to increase,” the electronics manufacturer said. “The seasonal performance for the current quarter is expected to be better than the range of the past five years.”
Near the start of 2026, Micron soared after Hon Hai announced better-than-expected Q4 sales.
Cigna reported earnings results that beat Wall Street estimates in Q4, but delivered underwhelming guidance for the year ahead.
For the last three months of 2025, Cigna reported:
Adjusted earnings per share of $8.08, compared to the $7.88 analysts polled by FactSet were expecting.
Revenue of $72.4 billion, compared to the $70.3 billion the Street was penciling in.
For the full year in 2026, Cigna expects:
Annual adjusted earnings per share of at least $30.25, compared to the $30.30 analysts were expecting.
Annual revenues of about $280 billion, compared to the $285.8 billion analysts had penciled in.
Its medical cost ratio to sit between 83.7% and 84.7%, where analysts had expected 83.9%.
Health insurers have been under pressure for the past year amid rising health costs, though Cigna has been outperforming its peers.
